Abstract Details

Title An Open-Label Extension Study To Determine the Safety of Pimavanserin in Patients with Parkinson's Disease and Psychosis

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 151

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Roger G. Mills, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
Hilde Williams	Hilde Williams has received personal compensation for serving as an employee of Vima Therapeutics, Inc.. The institution of Hilde Williams has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ProJenX Inc.. Hilde Williams has stock in PharmaStory Corp.. Hilde Williams has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
Stephen Revell, MD	No disclosure on file
	No disclosure on file

��ɫ��